Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Thaler

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1977
[Disseminated intravascular coagulation: antithrombin III and heparin]E Thaler
Wiener Klinische Wochenschrift|October 2, 1981
[Pathogenetic mechanism and clinical relevance of acquired anti-thrombin III deficiency in internal medicine (author's transl)]E Thaler
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 1, 2015
Response to Cassidy and CoteDavid E Thaler
Journal of the American College of Cardiology|May 9, 2020
Risk Management: "High-Risk" PFOs Come Into Partial FocusDavid E Thaler
Leber, Magen, Darm|October 1, 1982
[Hepatic coagulopathy--principles and therapeutic statements]E Thaler, G Kleinberger
Transactions - American Society for Artificial Internal Organs|January 1, 1974
A simple 2-step isolation procedure for human antithrombin II/III and its biological activity after insolubilization to agaroseE Thaler, G Schmer
Clinics in Haematology|June 1, 1981
Antithrombin III deficiency and thromboembolismE Thaler, K Lechner
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Affinity of antithrombin II/III to insolubilized heparinE Thaler, G Schmer
Haemostasis|January 1, 1993
An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myelomaS Panzer, E Thaler
Deutsche Medizinische Wochenschrift (1946)|January 29, 1982
[Antithrombin III deficiency: an important risk factor for venous thromboembolism]K Lechner, E Thaler
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1977
[Disseminated intravascular coagulation: antithrombin III and heparin]E Thaler
Wiener Klinische Wochenschrift|October 2, 1981
[Pathogenetic mechanism and clinical relevance of acquired anti-thrombin III deficiency in internal medicine (author's transl)]E Thaler
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 1, 2015
Response to Cassidy and CoteDavid E Thaler
Journal of the American College of Cardiology|May 9, 2020
Risk Management: "High-Risk" PFOs Come Into Partial FocusDavid E Thaler
Leber, Magen, Darm|October 1, 1982
[Hepatic coagulopathy--principles and therapeutic statements]E Thaler, G Kleinberger
Transactions - American Society for Artificial Internal Organs|January 1, 1974
A simple 2-step isolation procedure for human antithrombin II/III and its biological activity after insolubilization to agaroseE Thaler, G Schmer
Clinics in Haematology|June 1, 1981
Antithrombin III deficiency and thromboembolismE Thaler, K Lechner
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Affinity of antithrombin II/III to insolubilized heparinE Thaler, G Schmer
Haemostasis|January 1, 1993
An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myelomaS Panzer, E Thaler
Deutsche Medizinische Wochenschrift (1946)|January 29, 1982
[Antithrombin III deficiency: an important risk factor for venous thromboembolism]K Lechner, E Thaler
Pageof 12